NCT01242072 Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies Status UNKNOWN Phase PHASE1
NCT01240720 A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01235962 A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE3
NCT01235897 MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT01231932 Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors Status TERMINATED Phase N/A
NCT01231594 A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors Status COMPLETED Phase PHASE1
NCT01231581 Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01231568 An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor Status COMPLETED Phase PHASE1
NCT01231347 QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3
NCT01227889 A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma Status COMPLETED Phase PHASE3
NCT01225978 Refining Information Technology Support for Genetics in Medicine Status UNKNOWN Phase N/A
NCT01224730 A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01218854 A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy Status COMPLETED Phase PHASE1